Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial.

Autor:	Kaasch, Achim J1 (AUTHOR) achim.kaasch@med.ovgu.de, López-Cortés, Luis Eduardo2,3 (AUTHOR), Rodríguez-Baño, Jesús2,3 (AUTHOR), Cisneros, José Miguel3,4 (AUTHOR), Dolores Navarro, M3,4 (AUTHOR), Fätkenheuer, Gerd5 (AUTHOR), Jung, Norma5 (AUTHOR), Rieg, Siegbert6 (AUTHOR), Lepeule, Raphaël7 (AUTHOR), Coutte, Laetitia7 (AUTHOR), Bernard, Louis8 (AUTHOR), Lemaignen, Adrien8 (AUTHOR), Kösters, Katrin9 (AUTHOR), MacKenzie, Colin R10 (AUTHOR), Soriano, Alex11 (AUTHOR), Hagel, Stefan12 (AUTHOR), Fantin, Bruno13 (AUTHOR), Lafaurie, Matthieu14 (AUTHOR), Talarmin, Jean-Philippe15 (AUTHOR), Dinh, Aurélien16 (AUTHOR)
Zdroj:	Lancet Infectious Diseases. May2024, Vol. 24 Issue 5, p523-534. 12p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu